Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide for Early-to-Mid Stage Obesity-Related Knee Osteoarthritis
ChiCTR2200066291Phase 4Completed
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of semaglutide in knee osteoarthritis (OA) (2 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index and Body Mass Index. Started Jun 2022; status: completed.
02
Drugs
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2200066291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066291.